Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 1 |
2002 | 1 |
2007 | 1 |
2008 | 1 |
2009 | 1 |
2013 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.
Lancet. 2013.
PMID: 23433739
Clinical Trial.
Treatment of relapsed idiopathic thrombocytopenic purpura with the anti-CD20 monoclonal antibody rituximab: a pilot study.
Giagounidis AA, Anhuf J, Schneider P, Germing U, Söhngen D, Quabeck K, Aul C.
Giagounidis AA, et al. Among authors: anhuf j.
Eur J Haematol. 2002 Aug;69(2):95-100. doi: 10.1034/j.1600-0609.2002.02686.x.
Eur J Haematol. 2002.
PMID: 12366712
Clinical Trial.
Item in Clipboard
Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315).
Griesinger F, Sebastian M, Brueckl WM, Hummel HD, Jaeschke B, Kern J, Wesseler C, Jänicke M, Fleitz A, Zacharias S, Hipper A, Groth A, Weichert W, Dörfel S, Petersen V, Schröder J, Wilke J, Eberhardt WEE, Thomas M; CRISP Registry Group.
Griesinger F, et al.
JTO Clin Res Rep. 2023 Dec 25;5(4):100626. doi: 10.1016/j.jtocrr.2023.100626. eCollection 2024 Apr.
JTO Clin Res Rep. 2023.
PMID: 38586301
Free PMC article.
Item in Clipboard
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphoma.
Schütt P, Zimmermann K, Derks C, Ebeling P, Welt A, Poser M, Hense J, Metz K, Anhuf J, Sandmann M, Neise M, Moritz T, Stuschke M, Niederle N, Seeber S, Nowrousian MR.
Schütt P, et al. Among authors: anhuf j.
J Cancer Res Clin Oncol. 2009 Mar;135(3):459-66. doi: 10.1007/s00432-008-0467-2. Epub 2008 Aug 29.
J Cancer Res Clin Oncol. 2009.
PMID: 18758815
Clinical Trial.
Item in Clipboard
Long-term results of a phase-I/II study of sequential high-dose chemotherapy with autologous stem cell transplantation in the initial treatment of aggressive non-Hodgkin's lymphoma.
Welt A, Schütt P, Derks C, Ebeling P, Müller S, Metz K, Anhuf J, Moritz T, Seeber S, Nowrousian MR.
Welt A, et al. Among authors: anhuf j.
Tumori. 2007 Sep-Oct;93(5):409-16. doi: 10.1177/030089160709300501.
Tumori. 2007.
PMID: 18038870
Clinical Trial.
Item in Clipboard
[Histiocytosis X of the lung after successfully treated pulmonary metastatic ovarian carcinoma].
Ubrig-von Barany R, Anhuf J, Erlemann R.
Ubrig-von Barany R, et al. Among authors: anhuf j.
Radiologe. 2001 Jun;41(6):501-5. doi: 10.1007/s001170051062.
Radiologe. 2001.
PMID: 11458784
German.
Item in Clipboard
Cite
Cite